PENGUIN, NCT00855894: A Study of the Combination of Erlotinib and Pertuzumab in Patients With Relapsed Non-small Cell Lung Cancer |
|
|
| Completed | 2 | 41 | US, RoW | Pertuzumab, Perjeta, Erlotinib, Tarceva | Genentech, Inc., Roche Pharma AG | Non-Small Cell Lung Cancer | 03/12 | 03/12 | | |